Table 5. Multiplicative factor by which the odds ratios for Kaposi's sarcoma and non-Hodgkin's lymphoma increased in relation to a doubling of the anti-EBV antibody titre.

	Factor (95% CI)	Adjusted factor (95% CI)
Kaposi's sarcoma	1.1 (0.9–1.2)	1.0 (0.8–1.2)
Non-Hodgkin's lymphoma	1.3 (0.9–1.7)	1.5 (0.9–2.3)